Efficacy and safety analysis of anlotinib in combination with immune checkpoint inhibitors for second-line and subsequent extensive-stage small-cell lung cancer
-
Published:2024
Issue:03
Volume:71
Page:297-305
-
ISSN:1338-4317
-
Container-title:Neoplasma
-
language:
-
Short-container-title:neo
Author:
Ying Xixi,Shi Zheng,Shao Rongjun,You Guangxian,Song Zhengbo
Publisher
AEPress, s.r.o.